HSR21-063: Treatment Patterns Among Patients With EGFR Mutated Metastatic NSCLC Who Have Discontinued EGFR-TKI and Platinum-Based Chemotherapy Regimens

View More View Less
  • 1 Daiichi Sankyo, Inc., Basking Ridge, NJ
  • | 2 Analysis Group, Los Angeles, CA
  • | 3 Analysis Group, Montreal, Canada
  • | 4 Analysis Group, Boston MA
Restricted access

Corresponding Author: Elizabeth Marrett, MPH
All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 113 113 15
PDF Downloads 157 157 15
EPUB Downloads 0 0 0